Pre-Conference Lunch Short Courses
Monday, June 15, 2020 10:00 - 1:00 PM |
Short Course 1: Pre-Analytical Variables in Liquid Biopsy Testing - Recognizing, Planning and Mitigating Impacts on Your Test
Gregory Jones, Senior Director, Strategic Collaborations & Technical Affairs, Inivata, Ltd.
In this short course, a discussion of the pre-analytical variables in liquid biopsy testing will include describing known pre-analytical variables, preparing for unforeseen factors, defining the impacts of these variables on the assay, and how to mitigate for these impacts. The course will focus on use of risk analysis, guard band studies, and other validation approaches to define and limit such variables.
Greg Jones is currently an employee of Inivata, Inc where he is responsible for coordinating external strategic collaborations and is the technical subject matter expert for the company. Greg has 35 years of experience as the project lead in the development of IVDs including multiple BLA, PMA, 510K and LDT assays. In his career he has been responsible for assuring that the assays developed meet all regulatory requirements for the satisfactory validation and transfer to manufacturing or to the testing laboratory. He has worked at MDxHealth, BioMerieux and Organon Teknika in various product development and management roles.
Monday, June 15, 2020 1:30 - 4:30 PM |
Short Course 2: Liquid Biopsy from Bench to Bedside
Eric Konnick, MD, MS, FCAP, Assistant Professor, Department of Laboratory Medicine; Associate Director, Genetics and Solid Tumors Laboratory, University of Washington
Rena Xian, MD, MS, FCAP; Assistant Professor, Pathology and Oncology, Johns Hopkins Medical Institutions; Associate Director of Molecular Diagnostics Laboratories at Johns Hopkins Genomics
Christina Lockwood, PhD, DABCC, DABMGG, Associate Professor, Laboratory Medicine; Director, Genetics & Solid Tumors Laboratory; Medical Director, Brotman Baty Institute for Precision Medicine, University of Washington
Presentations will include:
Dr. Konnick is an Associate Director of the Genetics and Solid Tumors Laboratory and Director of Genetics Preanalytical Services at the University of Washington Medical Center in Seattle, and is board certified in Molecular, Anatomic, and Clinical pathology. He is vice chair of the Association for Molecular Pathology's (AMP) Professional Relations Committee and the College of American Pathologists (CAP) Genomic Medicine Committee. He has over 20 years of clinical laboratory experience and 8 years of experience in regulatory matters.
Dr. Lockwood is Director of the Genetics and Solid Tumors Laboratory and an associate professor of Laboratory Medicine at the University of Washington Medical Center. She is board-certified in clinical molecular genetics and clinical chemistry and received her Ph.D. in Cellular and Molecular Biology at the University of Wisconsin. Dr. Lockwood completed clinical postdoctoral fellowship training at the Washington University School of Medicine in St. Louis where she was also a faculty member. Dr. Lockwood's clinical expertise is the application of molecular methods to advance precision medicine for prenatal screening, genetic disorders, and molecular oncology. Her research focuses on the development and implementation of innovative genomic methods to guide patient care. She has most recently fostered clinical deployment of cell-free DNA diagnostics in pregnancy and oncology.
* The program is subject to change without notice, due to unforeseen reason.